Non-invasive prenatal tests

Cell-free foetal DNA blood tests are the most complete non-invasive prenatal tests that exist. They detect the presence of anomalies of chromosomes 21, 18 and 13 (Down, Edwards and Patau syndromes) and the most common anomalies generated by the sex chromosomes (X and Y).

Non-invasive prenatal tests

Cell-free foetal DNA blood tests are the most complete non-invasive prenatal tests that exist. They detect the presence of anomalies of chromosomes 21, 18 and 13 (Down, Edwards and Patau syndromes) and the most common anomalies generated by the sex chromosomes (X and Y).

What are non-invasive prenatal tests?

Thus, non-invasive prenatal tests are tests performed before the baby is born to detect abnormalities and do not involve any intervention on the foetus. Information about the baby is obtained through free foetal DNA in the mother’s blood.

They are the most complete non-invasive prenatal tests that exist today: with a simple test of the mother’s blood, they can detect in the future baby the presence of anomalies of chromosomes 21, 18 and 13 (Down, Edwards and Patau syndrome) and the most common anomalies generated by sex chromosomes (X and Y).

There are also more advanced versions of the free DNA in blood test that incorporate the detection of abnormalities of other chromosomes, mainly related to miscarriages in the first trimester, and that can identify losses of a fragment of certain chromosomes – disorders known as microdeletions – related to important genetic syndromes. These extended versions are requested when medically indicated in those cases in which certain abnormalities are detected by ultrasound.

In which cases are they indicated?

  • Women who wish to rule out the most frequent chromosomal abnormalities.
  • Women with high risk of chromosomal abnormalities after first trimester screening (hormonal and ultrasound analysis).
  • Women with a previous pregnancy with chromosomal abnormality (e.g., Down syndrome).
  • Women for whom ultrasound abnormalities have been detected that lead us to suspect a chromosomal abnormality.

 

In what cases is it indicated?

  • Women who wish to rule out the most frequent chromosomal abnormalities.
  • Women with high risk of chromosomal abnormalities after first trimester screening (hormonal and ultrasound analysis).
  • Women with a previous pregnancy with chromosomal abnormality (e.g., Down syndrome).
  • Women for whom ultrasound abnormalities have been detected that lead us to suspect a chromosomal abnormality.
RESULTS

90% of patients who undergo an assisted reproduction treatment at IVI become pregnant.

CARE

97% of our patients recommend IVI.
IVI provides personalised care and support during all stages of treatment.

TECHNOLOGY

IVI is a pioneer in the latest assisted reproduction technology in order to present the best results.

PRICE-QUALITY

We are not the most expensive choice. We offer the most treatment options in order to achieve the best results.

Results

Steps to follow to perform a non-invasive prenatal test

From the 10th week of pregnancy, a blood sample is collected from the expectant mother, which we send to the laboratory. For the study of chromosomes 21, 18, 13 and sex chromosomes, the results are ready in just three working days and our specialists can explain the results to you. In the case of the non-invasive prenatal test to detect alterations in all chromosomes and microdeletions, the results are available in 10 days.

Request your first appointment

Back to toparrow_drop_up